Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells
Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells. Shamri R, Dubois G, Erpenbeck VJ, Mankuta D, Sandham DA, Levi-Schaffer F. Clin Exp Allergy. 2019 Feb;49(2):255-257. doi: 10.1111/cea.13304. Epub 2018 Nov 25. PMID: 30379368
“Identification of biological and pharmaceutical mast cell and basophil related targets (WG3)” We like to welcome PhD-students and post-docs to the 3rd COST BM1007 training school
Offer: The laboratory of Dr Gaël Ménasché at Imagine Institute (https://www.institutimagine.org/en/gael-menasche-et-fernando-sepulveda-188) is looking for a full-time Postdoctoral Research Fellow to take on an exciting translational project
The Israel Academy of Sciences and Humanities established a prestigious program in 2018 to bring outstanding post-docs from around the world to Israel’s research universities. The